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Abstract
Mass-spectrometry-based proteomics has evolved as the preferred method for the analysis of
complex proteomes. Undoubtedly recent advances in mass spectrometry instrumentation have
greatly enhanced proteomic analysis. A popular instrument platform in proteomics research is the
LTQ-Orbitrap mass analyzer. In this tutorial we discuss the significance of evaluating and
optimizing mass spectrometric settings on the LTQ-Orbitrap during CID data-dependent
acquisition (DDA) mode to improve protein and peptide identification rates. We focus on those
MS and MS/MS parameters, which have been systematically examined and evaluated by several
researchers and are commonly used during DDA. More specifically we discuss the effect of mass
resolving power, preview mode for FTMS scan, monoisotopic precursor selection, signal
threshold for triggering MS/MS events, number of microscans per MS/MS scan, number of MS/
MS events, automatic gain control target value (ion population) for MS and MS/MS, maximum
ion injection time for MS/MS, rapid and normal scan rate and prediction of ion injection time. We,
furthermore, present data from the latest generation LTQ-Orbitrap system, the Orbitrap Elite,
along with recommended MS and MS/MS parameters. The Orbitrap Elite outperforms the
Orbitrap Classic in terms of scan speed, sensitivity, dynamic range, resolving power and resulting
in higher identification rates. Several of the optimized MS parameters determined on the LTQ-
Orbitrap Classic and XL were easily transferable to the Orbitrap Elite, whereas others needed to
be reevaluated. Finally, the Q Exactive and HCD are briefly discussed, as well as, sample
preparation, LC-optimization and bioinformatics analysis. We hope this tutorial will serve as
guidance for researchers new to the field of proteomics and assist in achieving optimal results.
Keywords
shotgun proteomics; CID data-dependent acquisition mode; identification rates; LTQ-Orbitrap;
MS and MS/MS parameters
INTRODUCTION
In recent years, mass spectrometry (MS) has emerged as a powerful technique to identify,
characterize and quantify proteins in complex biological samples. Shotgun approaches, in
which digested protein samples are analyzed by liquid chromatography-tandem mass
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spectrometry (LC-MS/MS) in a data-dependent acquisition (DDA)1 mode, are most
commonly used in proteomics analyses.
Developments and improvements in MS instrumentation have played a key role and
facilitated mass spectrometry-based proteomics. Particularly, hybrid LTQ-Orbitrap2,3 mass
spectrometers provide a powerful instrument platform for protein analysis and are
increasingly used in proteomics research. In the hybrid configuration the linear trap
quadrupole (LTQ, known as linear ion trap) is used as the front end for ion trapping, ion
selection, fragmentation reactions and low resolution ion detection, whereas the Orbitrap is
used for high resolution, high mass accuracy ion detection. The Orbitrap mass analyzer uses
electrostatic fields to trap and analyze ions and consists of one central spindle and one outer
barrel-like electrode.4–6 Ions injected into the Orbitrap are electrostatically trapped while
rotating and oscillating along the central electrode. Oscillating ions induce an image current
signal on the outer electrodes. Image current signals are converted into frequencies by
Fourier transformation. The frequencies, which are characteristic of each ion m/z value, are
finally converted into a mass spectrum.4–6 These hybrid instruments combine the sensitivity
and speed of the LTQ with the high mass accuracy and high resolution of Orbitrap2,3,6–8
mass analyzers. In addition, they can operate in two different detection modes. In the first
mode, the Orbitrap mass analyzer acquires the full MS spectra and the LTQ the MS/MS
fragment ion spectra, also called the FT-IT mode. In the alternative mode, both the MS and
MS/MS scans are analyzed in the Orbitrap detector. This mode is referred to FT-FT. Several
generations of Orbitrap mass spectrometers are currently available encompassing the
Classic, XL, Discovery, Velos, Velos Pro and Elite with the later generations offering also
HCD (high energy collision induced dissociation). For shotgun proteomics experiments the
FT-IT mode is the most widely employed. It should be noted though that the improved HCD
capabilities of the latest generation of hybrid instruments might very well change this in the
future.
LTQ-Orbitrap mass analyzers have enabled the analysis of thousands of proteins providing
insights beyond what is currently achievable with classical biological techniques.
Consequently, mass spectrometry-based proteomics has attracted considerable interest in the
biological community. In fact, an increasing number of researchers, who may not
necessarily be primarily interested in mass spectrometry, move into the field because they
realize that mass spectrometry-based proteomics will allow them to gain a greater
understanding of biological systems and cellular processes.
However, proteome analysis by LC-MS/MS can be challenging as it requires a basic
understanding and experience in mass spectrometry. In fact, familiarity with the entire
proteomics pipeline, including sample preparation, LC-MS/MS, and bioinformatics analysis,
is essential to achieve optimal results. Therefore, optimization of proteomics experiments
can be particularly demanding for proteomics researchers with limited experience in these
technologies.
In addition, when reviewing the proteomics literature it becomes apparent that the MS
parameters selected for global proteomics experiments can vary widely within the same and
between instrument platforms. Moreover, in a large number of publications, important
information about the MS methodology is not included. The heterogeneity and sometimes
even lack of instrument settings’ description make it even harder for proteomics researchers
to decide, which parameter to choose for their analyses.
These challenges have motivated several research groups to evaluate LC and MS settings
during DDA mode in order to examine their significance in the experimental outcome and
optimize instrument performance for a successful analysis. For LC optimization, reports
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have focused on the effect of the sample loading amount,9,10 sample loading conditions,11
flow rate, elution gradient range and length.10 In terms of MS parameters the effect of
dynamic exclusion,12,13 signal thresholds setting to trigger an MS/MS event,14 mass
resolving power,15 ion injection time,13 number of MS/MS,13 monoisotopic precursor
selection,13 preview mode for FTMS scan,16 normalized collision energy,13 AGC target
value (ion population) for MS and MS/MS scans,16 and number of microscans,16 have been
evaluated and discussed, aiming to examine the significance and effect of instrument
settings on identification rates. These reports revealed that LC and MS settings influence
identification rates and improved results can be obtained by optimizing instrument
performance.
In this tutorial we focus on the optimization of MS parameters on the widely used LTQ-
Orbitrap mass spectrometer for improved proteome coverage using CID as the
fragmentation technique. In addition recommended MS and MS/MS settings for the Q
Exactive are presented. Sample preparation, LC-performance and bioinformatics analysis
are also discussed. It should be noted that instrument settings may not necessarily translate
across different instrument platforms or different fragmentation techniques (i.e. ETD).
DATA-DEPENDENT ACQUISITION (DDA) SETTINGS
The DDA mode, in which the most intense peptide ions from a full MS scan are selected for
fragmentation, is by far the most widely used approach in shotgun proteomics experiments.
A DDA experiment consists of several MS and MS/MS parameters for which their values
need to be defined by the user. These include, but are not limited to, mass resolution,
monoisotopic precursor selection, preview mode for FTMS master scan, ion population
(AGC target value), and maximum ion injection time for the full MS scan. MS/MS
parameters include dynamic exclusion, minimal signal threshold, number of microscans per
MS/MS scan, number of MS/MS events, AGC target value and maximum ion injection time
for MS/MS. Even though it is advantageous to have the flexibility of deciding which of
these parameters will be used and which values will be selected, at the same time, the
various parameters and the wide range of values that these parameters can obtain,
complicate the design of a DDA experiment. In the following sections we discuss in detail
the significance of several MS and MS/MS parameters and their effect on protein and
peptide identification rates. MS and MS/MS parameters discussed herein are summarized in
Table 1 and suggested optimized values determined for the Orbitrap Classic and XL are
shown in Figure 1. Unless otherwise noted, results presented in the following sections were
obtained using an unfractionated tryptic digest of S. cerevisiae as the model system.
Mass Resolving Power
When the MS or MS/MS scans are detected in the Orbitrap mass analyzer, the mass
resolving power to be used during the scan event needs to be defined by the user. Usually in
shotgun proteomics experiments only the full MS scan is analyzed in the Orbitrap, whereas
the MS/MS scans are performed and analyzed in the linear ion trap. The resolving power of
the Orbitrap mass analyzer diminishes as the square root of the m/z ratio2,5 and during DDA
mode the selected setting is specified at 400 m/z. Consequently, the resolving power is not
steady across the m/z scan range and ions at higher m/z ratios are measured with lower
resolution as shown in Figure 2.
Acquiring data at higher resolving power results in better mass accuracy,4 but the scan
duration increases with increasing resolving power. Pandey and coworkers examined the
effect of different mass resolving power settings on identification rates using the Escherichia
coli proteome and a standard 48 protein mixture on an LTQ-Orbitrap XL.15 Both the FT-FT
detection mode (MS and MS/MS scans were analyzed in the Orbitrap) and the FT-IT mode
Kalli et al. Page 3
J Proteome Res. Author manuscript; available in PMC 2014 July 05.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
(MS scan was analyzed in the Orbitrap and MS/MS scans in the ion trap) were assessed.
Due to the longer scan cycle observed when employing the FT-FT method, a lower number
of MS/MS scans was obtained resulting in a significantly lower number of peptide spectrum
matches compared with the FT-IT method. Furthermore, the FT-IT experiments resulted in a
higher number of unique peptides and proteins. With the FT-IT method the number of
identifications was maximized at 30,000 resolving power, followed closely by 60,000
resolving power. The authors concluded that for shotgun proteomics experiments the FT-IT
method at a mass resolving power of 30,000 could maximize identification rates. In
applications in which high mass accuracy was essential the FT-FT method at a mass
resolving power of 15,000 (for both the MS and MS/MS scans) provided the best comprise
between speed, accuracy and identification rates.15
Preview Mode for FTMS Master Scan
The preview mode for FTMS master scan is another parameter used during DDA for
triggering MS/MS events. When the preview mode is enabled, a preview scan in the FT-
Orbitrap analyzer is performed at lower resolution and precursor ions subjected to MS/MS
are selected based on the preview scan. A high resolution MS spectrum and MS/MS scans
are then acquired in parallel. With the preview mode disabled, the high resolution MS scan
is performed first, followed by the MS/MS scans. In the latter setting a slightly longer cycle
time is required. We have recently examined the effect of enabling and disabling the
preview mode for FTMS scan on protein and peptide identification rates using the S.
cerevisiae proteome as a model system.16 Due to the faster duty cycle a higher number of
acquired and identified MS/MS spectra were observed by enabling the preview mode scan.
Despite the higher number of acquired and identified MS/MS spectra, comparable results in
terms of identification rates were obtained regardless of whether this option was enabled or
not. Therefore, we can conclude that the preview mode for FTMS scan has no significant
effect on identification rates, but it allows for a faster duty cycle.16
Monoisotopic precursor selection
During DDA mode, monoisotopic precursor selection can be enabled or disabled. By
enabling this option, only the monoisotopic peak of the overall isotopic distribution will be
selected for fragmentation. By disabling this option every isotopic peak in the full MS scan
becomes accessible to fragmentation. The influence of monoisotopic precursor selection on
proteome coverage was evaluated by Muddiman and coworkers13 using the design of
experiments17 approach. A tryptic digest of S. cerevisiae was used as the model system. The
authors showed that monoisotopic precursor selection significantly influences proteome
coverage and that enabling this option results in an increase in proteome coverage. In
addition to the monoisotopic precursor selection, they determined that the maximum ion
injection time and the number of MS/MS events also affect identification rates.13 These two
parameters are discussed in more detail in the following sections.
Minimum Signal Threshold
This setting refers to the minimum ion abundance (intensity) required for a precursor ion in
the full MS scan to be automatically selected for fragmentation during DDA mode.
Increasing the signal threshold will result in lower number of acquired MS/MS spectra but
the overall quality of the MS/MS spectra will increase. Decreasing the level of the signal
threshold will result in a large number of MS/MS events, but the quality of the MS/MS
spectra arising from low intensity ions may be insufficient for identification or the MS/MS
spectra may be derived from chemical noise.
The effect of signal threshold level from 1 × 101 to 1 × 107 intensity units on peptide and
protein identifications was investigated by Yates and coworkers, using unfractionated yeast
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peptide mixture, to determine the optimal value for maximizing identification rates.14 For
signal thresholds at and below the noise level of the mass analyzers comparable results were
obtained for the number of acquired MS/MS spectra and identified peptides and proteins.
Therefore, the authors concluded that the optimal threshold setting is around the noise level
of the mass analyzer. When the MS scan is performed in the LTQ they suggested a threshold
setting of ca. 1 × 104 intensity units and when the MS scan is acquired in the Orbitrap a
value of ca. 1 × 105 intensity units was proposed.14
Number of Microscans per MS/MS scan
The number of average microscans to produce one MS/MS scan is another variable during
DDA. Increasing the number of microscans improves the signal to noise ratio but also
increases the scan cycle time resulting in the collection of less MS/MS spectra. We have
evaluated the effect of the number of microscans in shotgun proteomics experiments for
maximizing proteome coverage.16 As expected, increasing the number of microscans
resulted in an increase in the scan cycle time and a considerably lower number of acquired
MS/MS spectra. A 72% decrease in the number of acquired MS/MS spectra was observed
by increasing the number of microscans from one (27139 MS/MS events) to five (7597 MS/
MS events). Consequently, a lower number of identified protein groups was obtained when
averaging 5 microscans per MS/MS scan. Employing one microscan resulted in 1052 (±20)
protein groups identification, whereas 5 microscans resulted in 584 (±6) identifications.
These results suggest that one microscan provides a CID MS/MS spectrum of sufficient
quality for peptide and subsequent protein identification.
Number of data-dependent MS/MS Events
The number of data-dependent MS/MS scans can also be defined by the user during a
shotgun proteomics experiment. Increasing the number of MS/MS scans will generally
allow more precursor ions from the MS scan to be selected for fragmentation but the actual
number of MS/MS scans performed also depends on the duration of the scan cycle and on
the number of peptide candidates in the MS scan.
It has been shown that the number of MS/MS scans significantly affects proteome
coverage.13,16 By evaluating the effect of data-dependent MS/MS scans at different AGC
target values and different ion injection times for MS/MS (5 × 103/50 ms, 5 × 103/150 ms,
and 1 × 104/50 ms) we have shown that 12 to 15 MS/MS outperformed 5 to 10 MS/MS
events for all three tested settings. For instance, at an AGC target value of 1 × 104 and
maximum ion injection time of 50 ms, 5 and 12 MS/MS events resulted in 806 (±47) and
1113 (±12) protein groups identifications, respectively. Similar trends were obtained for the
number of identified and unique peptides. Further increasing the number of data-dependent
MS/MS scans to 20, did not provide any apparent benefit in the Orbitrap Classic. Therefore,
improved proteome coverage can be achieved by increasing the number of MS/MS events to
12 – 15.16
AGC (Automatic Gain Control) Target Value
The AGC target value refers to the ion population in the linear ion trap or Orbitrap mass
analyzer. The idea behind the AGC is to regulate the number of ions in the mass analyzer in
order to avoid or minimize space charge effects to improve mass accuracy. It is important to
note that the AGC target value and maximum ion injection time are not independent
parameters. The MS or MS/MS events are controlled by either the AGC target value or the
maximum ion injection time depending on which parameter is reached first. For example, if
the AGC target value is set at 1 × 104 and the maximum ion injection time at 50 ms but it
takes longer than 50 ms to accumulate 1 × 104 ions then the MS/MS (or MS) events will be
performed with 50 ms regardless of the set AGC target value. If it takes less time (<50 ms )
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to accumulate 1 × 104 ions then the MS/MS (or MS) events will be performed with the
selected AGC target value.
Table 2 summarizes set and actual MS and MS/MS ion injection times observed in the LTQ-
Orbitrap Classic for different AGC target values during LC-MS/MS analyses of
unfractionated tryptically digested yeast lysate. As illustrated in Table 2 by increasing the
AGC target values the maximum ion injection time also increases since it takes longer to
accumulate a higher number of ions.
The effect of AGC target values for MS and MS/MS events on identification rates has been
recently evaluated.16 AGC target values of 5 × 105 to 1 × 106 for the full MS scan result in
very similar identification rates, with 1001 and 1013 protein groups identified at AGC target
values of 5 × 105 and 1 × 106, respectively. Increasing the AGC target value to 2 × 106 and
3 × 106 ions results in a lower number of identified peptides, unique peptides and identified
protein groups. In addition, at higher AGC target values (≥ 2 × 106) some mass deviation on
precursor ions’ mass accuracy is observed due to space charge effects and the percentage of
identified MS/MS spectra decreases.16
For the MS/MS AGC target values comparable results are obtained for 3 × 103 − 1 × 104
ions resulting in 1035 to 1086 protein groups. Significantly lower identification rates for
both peptides and protein groups are observed for ion populations of 5 × 104 and 1 × 105. By
increasing the AGC target value for MS/MS, the MS/MS scan rates decrease as it takes
longer to accumulate a higher ion population resulting in a lower number of acquired MS/
MS. In addition, setting the AGC target value very low at 1 × 103 ions also results in lower
identification rates, presumably due to the lower quality of MS/MS spectra. This assumption
is also supported by the fact that the percentage of identified MS/MS spectra decreases at
AGC target values of 1 × 103.16 Based on these observations it was concluded that an ion
population of 5 × 105 to 1 × 106 for MS scans and an ion population of 3 × 103 to 1 × 104
for MS/MS events provide optimal results.16
Maximum Ion Injection Time for MS/MS events
The maximum ion injection time is the maximum time that ions are allowed to accumulate
in the linear ion trap or the C-trap, before being transferred to the Orbitrap, provided that the
AGC target value has not been reached first as discussed above. Setting the ion injection
time very high (e.g.; > 1000 ms) can result in significantly longer scan cycle times in cases
of weak or no signals because in such circumstances the AGC target value is not reached
and the MS/MS events will be performed based on the selected maximum ion injection time.
The effect of the maximum ion injection time on proteome coverage has been previously
evaluated.13,16 In general, it has been shown that lower ion injection times of 50–150 ms are
correlated with higher identification rates. For instance, for an MS/MS AGC target value of
8 × 103 an ion injection time of 80 ms resulted in more peptide and protein identifications
when compared with an ion injection time of 400 ms.13 For ion population of 5 × 103 and 1
× 104, optimal results were obtained in the range of 50–100 and 50–150 ms, respectively.16
Using an ion population of 5 × 103 for MS/MS and an ion injection time of 50 ms, 1049
protein groups and 7913 peptides were identified, versus 1008 proteins groups and 7236
peptides at 500 ms ion injection time.16 Ion injection times above 100 or 150 ms did not
provide any benefit and overall a decrease in identification rates was observed.
It is worth noting that electrospray conditions significantly affect ion injection times,
therefore considerable attention should be given in achieving optimized and stable
electrospray conditions. Electrospray emitter tips and ESI voltages should be carefully
chosen. Under optimized electrospray conditions and sufficient sample concentration the
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actual MS and MS/MS injection times should be low. As illustrated in Table 2 the actual MS
and MS/MS ion injection times are low, except in cases in which the AGC target values are
set at high values. Newer generation visualization tools, such as LogViewer18 (http://
pel.caltech.edu/software/) or RawMeat (http://vastsci.com/rawmeat/), which display ion
injection times in addition to several other parameters, can be used to assess whether the
MS/MS events were performed based on the AGC target value or the ion injection time and
also assist in the optimization process.
It should be noted that in cases in which the MS/MS events are analyzed in the Orbitrap
mass analyzer, injection times are considerably higher when compared to those analyzed in
the ion trap. This is mainly due to the fact that a higher number of ions are required for
detection in the Orbitrap and thus longer ion injection times are needed for accumulation of
the desired number of ions.
Additional MS Parameters during DDA Mode
Besides the DDA settings discussed above, there are several other MS and MS/MS
parameters commonly used during DDA acquisition. These parameters are briefly discussed
below.
The isolation width is the m/z range that the MS detector uses to isolate the precursor ions.
Setting the isolation width too narrow will result in loss of sensitivity, and in extreme cases
cut out a portion of the ion packets, thus resulting in inaccurate measurements. In contrast, a
wide isolation window may result in co-isolation and co-fragmentation of neighboring
peptides resulting in unidentifiable or low scoring spectra. The isolation width is usually set
at 2 to 4 m/z10,14,15,19–24 and it has been suggested that that these typically used values (2 to
4 m/z) are optimal in practice.25
For shotgun proteomics experiments, the collision energy and activation time for CID are
generally set at 35% and 30 ms,11,14,15,19–21,23,26–30 respectively. In addition, it has been
shown that the collision energy does not significantly affect identification rates.13
In terms of charge states selected for fragmentation, usually singly charged ions and
unassigned charge states are rejected.10,13,20,21,23,27,29–33 This is mainly due to the fact that
the majority of peptides derived from proteolytic digestions (i.e; trypsin, Lys C, Glu C) are
multiply charged following electrospray ionization. Although some proteolytically derived
peptides are singly charged these are in general small in size. Given that during database
searching a minimum peptide length of 6 or 7 amino acids is required for confident peptide
identification these small size peptides will be filtered out and therefore collecting MS/MS
spectra on these peptides provides no benefit. In addition, singly charged species are more
likely to be contaminant ions and thus provide no useful information. By excluding them
from fragmentation, all available time for MS/MS is devoted to multiply charged ions and
no analysis time is wasted in collecting uninformative MS/MS scans or MS/MS spectra,
which will be filtered during data analysis.
Dynamic exclusion duration is another commonly used MS parameter and it can either be
enabled or disabled. If enabled, an exclusion duration value should be determined by the
user. Ideally, the dynamic exclusion should be matched to the peak width of the individual
peaks in a chromatogram. With dynamic exclusion enabled a precursor ion for which an
MS/MS event has been triggered is placed on an exclusion list and will be excluded for
repeated MS/MS analysis for a specified time, called exclusion duration. The exclusion list
on all Orbitrap mass spectrometers is currently limited to 500 precursor ions. When the
dynamic exclusion is disabled, repeated MS/MS scans of the most abundant precursor ions
will be generated. In shotgun proteomics experiments the dynamic exclusion is normally
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enabled to minimize repeated sequencing of peptides and allow for new precursor ions to
undergo fragmentation. Commonly used values for dynamic exclusion duration are 60, 90 or
180 sec with one repeat count and 30 sec repeat duration.3,10,11,15,19,21,25,27,34,35 Muddiman
and coworkers evaluated the effect of dynamic exclusion duration by comparing 30 and 180
sec and found that dynamic exclusion duration had a minimal effect on identification rates.13
Two additional parameters of the dynamic exclusion settings are the exclusion mass width
and early expiration. In our laboratory we set the exclusion mass width to 10 or 15 ppm and
enable early expiration as these settings, in our hands, result in higher identification rates.
Orbitrap Elite
The hybrid Orbitrap Elite36 is the latest generation of the Orbitrap mass analyzers family.
This instrument features higher resolving power, up to 240,000 at m/z 400, compared to the
100,000 resolving power of the earliest generation. In addition, the Orbitrap Elite offers
improved dynamic range and faster scan rates than its predecessors. A detailed description
of hardware and software improvements implemented in the Orbitrap Elite can be found in a
recent publication.36
We felt that this tutorial would not be complete without covering and presenting the
optimized DDA settings for the hybrid Orbitrap Elite. Therefore, we performed a similar
analysis to that performed for the Orbitrap Classic and XL13–16 to determine optimized MS
and MS/MS settings for the Orbitrap Elite during DDA mode. For direct comparison we
used tryptic digest of unfractionated yeast lysate. The parameters examined, with their
recommended settings, are summarized in Table 3.
Several of the optimized settings determined for the Orbitrap Classic and XL are easily
transferable to the Orbitrap Elite. For instance, the optimized settings for the AGC target for
the MS and MS/MS scans determined for the Orbitrap Elite are identical to those determined
for the Orbitrap Classic and XL. The effect of maximum ion injection time on identification
rates is shown in Figure 3. These data clearly demonstrate that the observed trends are
similar to those obtained for the Orbitrap Classic.16 Although, differences in the
identification rates are not statistically significant (ANOVA analysis resulted in p-values of
0.55), there is no apparent advantage of increasing the ion injection time, as discussed
above. Therefore, we recommend setting the ion injection time at 30 to 100 ms for the MS/
MS scans.
Based on the data obtained on the Orbitrap Classic,16 for the number of MS/MS scans we
examined only 15 and 20 MS/MS events. We have not observed any significant increase in
the number of identified peptides or protein groups by increasing the number of MS/MS to
20. The number of identified peptides, unique peptides and protein groups was 14706,
13196 and 2151, respectively, with 15 MS/MS. With 20 MS/MS scans 14008 peptides,
12703 unique peptide and 2111 protein groups were identified in unfractionated yeast
samples. It should be pointed out that for more complex samples, such as an unfractionated
peptide mixture from human or mouse cell lines, increasing the number of MS/MS to 20
might be advantageous. In fact, in previous reports in which a peptide mixture from a tryptic
HeLa digest was analyzed, 20 MS/MS events were selected for CID performed on the LTQ-
Orbitrap Velos30 and Orbitrap Elite.36
A major improvement of the Orbitrap Elite is the reduced trap dimension of the Orbitrap
mass analyzer leading to a higher field strength. The higher field strength results in an
almost twofold increase in resolving power at the same scan time compared to the previous
Orbitrap generations. Therefore, the MS scans can be performed at higher resolving power
without significantly increasing the cycle times. In addition to achieving better mass
accuracy,4 a higher number of isotope patterns can be detected36 by acquiring data at higher
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resolving power. Since the improvement in resolving power constitutes a major difference
between the Orbitrap Elite and its predecessors, the effect of MS resolving power on
identification rates was reevaluated to assess the optimum value for the Orbitrap Elite.
Increasing the MS resolving power from 30,000 to 120,000 results in a concomitant increase
in identification rates by 21% for protein groups and by 30% for identified peptides (Figure
4). Further increasing the resolving power to 240,000 causes a decrease in the number of
identified peptides and protein groups. The decrease in identification rates observed at
240,000 resolving power can be attributed to the lower number of acquired MS/MS scans
(37,369 ± 411 at 240,000 resolution versus 38,950 ± 275 at 120,000 resolution) and to the
lower percentage of identified MS/MS spectra (38% ± 0.39 at 240,000 resolution versus
43% ± 0.39 at 120,000 resolution). ANOVA analysis revealed that differences in
identification rates were statistically significant as the obtained p-values were 0.00083,
0.00077 and 0.00017 for the number of identified peptides, unique peptides and protein
groups, respectively. Therefore, for the Orbitrap Elite a resolving power of 120,000 provides
optimum results, whereas for the previous Orbitrap generation instruments optimal results
are obtained at a resolving power of 30, 000 or 60,000.
It is worth pointing out that for the analysis of a tryptic HeLa digest on the Orbitrap Elite it
was shown that a resolving power of 240,000 resulted in a higher number of isotope clusters
being detected and therefore a 240,000 resolution survey scan was selected for subsequent
analysis.36 These observations36 are in contrast with our observations, in which we
determined that a resolving power of 120,000 resulted in higher identification rates. One
plausible explanation for this discrepancy could be the different sample employed in the two
investigations. The digested HeLa lysate is more complex compared to the yeast lysate we
used in our investigations. It is reasonable to assume that the higher resolving power is
advantageous for more complex samples as the complexity of the sample will result in an
increase in the number of peptides eluting at a given time and therefore in an increase in the
number of peptide features (isotope clusters). In addition to different sample complexity,
different sample amount and gradient time were used and also MS settings were not
identical between the two investigations. These factors might contribute to the different
resolving power setting determined as optimum between the two reports.
The Orbitrap Elite features two different CID scan modes, one with rapid scan rate and the
other with normal scan rate. As the name implies, the rapid scan mode is faster than the
normal scan mode. With the rapid scan mode up to 12.5 MS/MS spectra can be acquired per
second.36 The data obtained by selecting the rapid and normal scan rata is displayed in Table
4A. A higher number of MS/MS spectra are collected with the rapid scan rate, as expected,
but this does not translate to significantly higher identification rates. Nevertheless, there is
no drawback of selecting the rapid scan mode and, in fact, it might be advantageous for very
complex samples as it allows more MS/MS scans to be acquired.
Increasing the number of fragmentation events can also be achieved by enabling the
prediction for ion injection time. By enabling this option the Orbitrap MS analyzer skips the
data-dependent MS/MS prescan and uses the intensity of the parent ion present in the MS
scan to determine the ion injection time for the MS/MS events. Therefore, more MS/MS
scans can be triggered across a chromatographic peak. Table 4B displays the data obtained
by enabling and disabling this option. Indeed by enabling the ion prediction time, the
number of fragmentation events increases by 19 % and a higher number of identified
peptides and protein groups is observed compared to the data obtained by disabling this
option.
Similar to the results obtained on the Orbitrap XL13, we observed that enabling the
monoisotopic precursor selection results in higher identification rates on the Orbitrap Elite.
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More specifically by enabling this option an increase of 18 % was observed in the number of
identified proteins. We also examined the effect of the exclusion mass width. By setting the
exclusion mass width to 0.51–1.51 m/z, we observed a decrease of 26% in the number of
identified protein groups compared to the results obtained by setting the exclusion mass
width to 15 ppm.
Finally, for the Orbitrap Elite, at a resolving power of 120,000, disabling the preview mode
for FTMS results in higher number of peptide and protein groups identifications. Therefore,
disabling this option is recommended for the Orbitrap Elite.
In Table 5, the data obtained over three replicate LC-MS/MS analyses performed under the
same experimental conditions is summarized. Small run-to-run variations are observed in
terms of identification numbers indicating good repeatability. The data-dependent settings
used were 1 × 106 ion population for the MS scan and ion injection time of 200 ms, 5 × 103
ion population for the MS/MS scan and ion injection time of 50 ms. The resolving power
was set to 120,000 and the 15 most intense ions (15 MS/MS scans) were selected for
fragmentation. The rapid scan mode was selected, the prediction of ion injection time was
enabled and the preview mode for the FTMS scan was disabled. Dynamic exclusion was
enabled with a repeat count of 1, repeat duration of 50, exclusion list size of 500 and
exclusion duration of 90 sec. Exclusion mass width was set to 15 ppm and early expiration
was enabled. CID was performed at a normalized collision energy of 35% and the isolation
width was set to 2 Da. With these data-depending settings an average of 14,207 (± 1,095)
peptides and 2,113 (± 78) protein groups (≥2 peptides) were identified.
A direct comparison of the Orbitrap Classic and Orbitrap Elite is displayed in Figures 5 and
6. As it is clearly illustrated in these Figures, the Orbitrap Elite outperforms the Orbitrap
Classic in terms of identification rates. A two fold increase in the number of identified
protein groups and identified peptides is observed with the Orbitrap Elite (Figure 5). For
proteins with more than 10,000 copies per cell37, the number of identified proteins is
comparable between the two instruments but for proteins with 100–10000 copies per cell37
the Orbitrap Elite identified 942 more proteins corresponding to a 2.7 fold increase
compared to the Orbitrap-Classic (Figure 6). It is also worth pointing out that for the LC-
MS/MS analysis on the Orbitrap Classic, 1.2 µg of unfractionated yeast lysate was used
versus 0.2 µg for the Orbitrap Elite. Therefore, in addition to the increase in identification
rates, an enhanced sensitivity is also achieved by the Orbitrap Elite.
Q Exactive and HCD
The Q Exactive38, introduced in 2011, represents another member of the Orbitap mass
analyzers family. The Q Exactive features a quadrupole mass filter at the front end and
unlike the LTQ-Orbitrap mass analyzers it is not a dual detector instrument (the Orbitrap
mass analyzer is the only detector on the Q Exactive configuration) and thus, it does not
have CID capabilities. HCD, in which both the precursor and product ions are analyzed in
Orbitrap analyzer is, currently, the only available fragmentation technique on the Q
Exactive. The quadrupole mass filter allows transfer of specified mass range ions into the C-
trap for accumulation improving sensitivity for MS/MS experiments. In addition, the Q
Exactive provides high mass accuracy, low detection limits, resolving power up to 140,000
at m/z 200 (note that this is in contrast to the LTQ-Orbitrap instruments where the resolving
power is defined at m/z 400) and allows up to 12 high-resolution MS/MS spectra per
second. These features make the Q Exactive a suitable instrument platform for analysis of
complex proteomes.38–40
The performance of the Q Exactive was evaluated using 5 µg of unfractionated tryptic
digests of HeLa cell lysate over a 90 min gradient.38 HCD was performed at collision energy
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of 30 eV and at a resolution of 17,500 (at m/z 200). Ten data-dependent MS/MS scans were
selected per MS scan. The other MS and MS/MS data-dependent settings used are displayed
in Table 7. On average 12,563 unique peptides and 2,557 protein groups were identified.
The total number of identified unique peptides and protein groups over a triplicate analysis
were 16,255 and 2,864, respectively.38
The Q-Exactive was recently coupled with ultra-high pressure liquid chromatography for the
analysis of unfractionated Lys-C digested yeast cell lysate.40 HCD was performed on the 10
most abundant precursor ions with a collision energy of 25 eV, maximum ion injection time
of 60 ms and AGC target value of 1 × 106. In order to increase proteome depth a long 4h
gradient using a 50 cm analytical LC column and small particle sizes (1.8 µm) was used. Six
LC-MS/MS analyses were performed and 4 µg of the unfractionated peptide mixture was
loaded per run. An average of 4,084 ± 8 and a total of 4,206 proteins were identified with
4,026 proteins being identified by at least two peptides. These results demonstrated that the
Q Exactive with its HCD capabilities is well suited for the analysis of complex peptide
mixtures providing high proteome coverage.40
Furthermore, it has been demonstrated that peptide and protein identification rates on the Q-
Exactive are dependent on sample amount, acquisition speed and data quality.39 These
observations are analogous to the results observed for the LTQ-Orbitrap mass analyzers.
Two acquisition HCD methods, one optimized for sensitivity (termed sensitive method) and
the other optimized for speed (termed “fast” method), were evaluated for the analysis of
yeast and HeLa tryptic peptide mixtures. For the sensitive acquisition method the ion
injection time was set at 120 ms and the resolution was 35,000, whereas for the fast method
the ion injection time was 60 ms and the resolution was set at 17,500. For both methods the
AGC target value for MS/MS was set at a very high number (5 × 105) to ensure that all MS/
MS events were performed at the desired maximum ion injection time. The 12 most
abundant precursor ions were selected for fragmentation. All other data-dependent
acquisition settings were identical between the two methods (Table 7). The authors reasoned
that the fast scanning method would be more suitable for the analysis of complex and
abundant peptides, while the sensitive method would be better suited for low-complexity
and low abundant samples since the longer ion injection times employed in the sensitive
method will result in better quality MS/MS spectra. Indeed, at a low sample concentration (<
125 ng) of a tryptic yeast digest the sensitive method resulted in a higher number of peptide
spectra matches and identified peptides, whereas at concentration ≥ 125 ng the fast method
outperformed the sensitive method.39
The fast and sensitive acquisition methods were also evaluated for the analysis of
unfractionated tryptic HeLa digests over three different gradient lengths. It was shown that
for gradient lengths of 60 and 120 min the fast method resulted in a higher number of
identified peptides and protein groups, whereas for a gradient length of 180 min higher
identification rates were observed with the sensitive method. More specifically for the 60
min gradient, 2,109 protein groups were identified with the sensitive method and 2,814 with
the fast method. For a gradient length of 120 min an average of 3,580 and 3,821 protein
groups were identified with the sensitive and fast method, respectively. For the longer 180
min gradient evaluated, the sensitive method resulted in 4,097 protein groups identifications
versus 3,905 protein groups identified with the fast method. Based on these observations the
authors reemphasized the importance of optimizing acquisition methods based on the
amount loaded and analysis time. 39
HCD fragmentation is also available on the LTQ-Orbitrap XL, Velos and Elite. The HCD
performance on the LTQ-Orbitrap Velos and Q Exactive has been compared using
unfractionated HeLa lysate,38 yeast lysate39 and RAW 264.7 lysate41 as the model systems.
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During a 60 min gradient of a 250 ng yeast peptide mixture, the LTQ-Orbitrap Velos
identified on average 4,491 unique peptides, whereas 10,784 or 8,572 unique peptides,
depending on the sensitive or fast acquisition method used (see discussion above), were
identified with the Q Exactive.39 Similar results were obtained for the analysis of 5 µg HeLa
tryptic digests over a 90 min gradient.38 Ten HCD MS/MS were selected for both
instruments and the resolution was set at 17,500 (at m/z 200) on the Q Exactive and at 7,500
(at m/z 400) for the Orbitrap Velos (details on the acquisition settings are depicted on Table
7). On average 1,881 and 2,557 proteins were identified on the LTQ-Orbitrap Velos and Q
Exactive, respectively. The authors pointed out though, that a detailed comparison between
the two instruments requires additional experiments and also that the LTQ-Orbitrap Velos
has CID and ETD capabilities, which are not available on the Q Exactive.38 The
performance of HCD between the two instrument platforms was further evaluated for
different sample loading amounts (1 to 1000 ng).41 It was shown that for sample amounts ≥
10 ng the Q Exactive outperformed the LTQ-Orbitrap Velos. For 1 and 5 ng of RAW 264.7
cell lysate, depending on the HCD acquisition method used on the Q Exactive, identification
rates were found to be higher or lower compared to the LTQ-Orbitrap Velos. These
observations reemphasize the importance of optimizing acquisition settings. The authors
also compared CID on the LTQ-Orbitrap Velos with HCD on the Q Exactive and reported
that HCD outperformed CID.41 Overall, these reports38,39,41 demonstrated that HCD
performed on the Q Exactive results in a higher number of identified peptides and proteins
compared to HCD performed on the LTQ-Orbitrap Velos highlighting improvements in
instrumentation. Identification rates obtained by HCD on the Orbitrap Elite were also
reported by analyzing 400 ng of an unfractionated tryptic HeLa digest over a 2h gradient
using 15 HCD MS/MS events per MS scan (see Table 8 for additional acquisition
settings).36 HCD resulted in an average of 10,740 unique peptides and 2,073 protein groups.
Furthermore a comparison between CID and HCD on the Orbitrap Elite was also performed.
The 20 most abundant precursor ions were selected for CID fragmentation and a slightly
higher number of identified protein groups, 2,268, was obtained when compared to HCD.
The authors pointed out that the peptide identification numbers obtained in CID and HCD
performed on the Orbitrap Elite were significantly improved compared to the results
obtained on the LTQ-Orbitrap Velos.36
Tables 6 and 7 summarize MS and MS/MS acquisition settings commonly employed by
different groups for CID and HCD analyses performed on LTQ-Orbitrap Classic, LTQ-
Orbitrap XL, LTQ-Orbitrap Velos, Orbitrap Elite and Q Exactive. These values could serve
as a starting point when optimizing acquisition settings for proteomics analysis on different
Orbitrap mass analyzers platforms.
SAMPLE PREPARATION, LIQUID CHROMATOCRAPHY AND
BIOINFORMATICS ANALYSIS
Sample preparation, including protein extraction, protein solubilization/denaturation,
reduction/alkylation, proteolytic digestion and sample cleanup prior to LC-MS/MS analysis,
is a fundamental step for successful peptide and protein identifications in shotgun
proteomics. In fact, the quality of the sample to be analyzed largely influences the data
obtained in a proteomics experiment and thus considerable attention should be given during
sample preparation. It should be pointed out that there is no single method, which is
applicable to all possible samples. Therefore, the sample preparation method should be
carefully and experimentally optimized based on the nature of the sample and on the
biological question to be addressed. For instance, different sample processing protocols are
followed for protein extraction from i.e. cell lysates, tissues, biological fluids, plants and
bacteria. In addition, certain protein classes such as membrane proteins and post-
translationally modified proteins require additional steps, such as enrichment procedures and
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protein solubilization, for successful identification. The importance of optimizing sample
preparation has been demonstrated by Winter and Steen, who have carefully optimized the
cell lysis, protein precipitation and digestion protocols for the widely used HeLa S3.42 The
authors demonstrated that improved peptide and protein identification rates can be achieved
using an optimizing protocol. For instance, by optimizing the digestion protocol the authors
were able to obtain a 3.5 and 2.7 fold increase in the number of identified peptides and
proteins, respectively.42
Description on sample preparation strategies based on the nature of the sample and the
properties of the target proteins is out of the scope of this tutorial and discussion on these
topics can be found in published reports and references therein.42–60
In this tutorial, we briefly discuss several steps during sample preparation that are generally
applicable to a wide range of proteomics samples. Possible problems and ways to overcome
these are also discussed. Regardless of the nature of the sample, an efficient proteolytic
digestion producing peptides with high yields, preferentially for the vast majority of proteins
present, undoubtedly facilitates and improves protein identification. Many proteases i.e.
trypsin, Lys-C, Lys-N, Glu-C, Asp-N, chymotrypsin and pepsin, are available for protein
digestion and each enzyme features its own specificity, efficiency and optimum digestion
conditions. Missed cleavages, unspecific cleavages and incomplete digestion are factors that
need to be considered during the digestion step and database search. Time should be devoted
in optimizing digestion conditions such as enzyme to substrate ratio, temperature, reaction
time, buffer and pH in order to minimize missed cleavages, unspecific cleavages and
incomplete digestion.
Enzymatic missed cleavages are due to incomplete hydrolysis reactions between the
substrates and enzymes. The number of missed cleavages will negatively affect peptide
identification rates in cases in which mis-cleaved peptides are present but the search was
performed with zero missed cleavages. Brownridge and Beynon analyzed mis-cleaved
peptides in a trypsin digest of yeast extract and reported that 1,415 ± 88 mis-cleaved
peptides were identified over four biological replicates. Of these 51% were N-terminal mis-
cleaved peptides and 32% were C-terminal containing short extensions (up to five amino
acids) at the N-terminus and C-terminus respectively.61 Furthermore, it has been shown that
the digestion temperature, reaction time, enzyme to substrate ratio and digestion buffer
affect the number of missed cleavages during conventional and microwave-assisted trypsin
digestion.62 To account for the presence of mis-cleaved peptides a maximum of two missed
cleavages is commonly allowed in database searches. Incomplete digestion may arise from
factors such as limited protein solvation or denaturation, short reaction times, low enzyme
concentration, digestion solution pH, and low protein accessibility to the enzyme.63,64 It is
highly recommended to quantify the amount of the protein to be digested in order to allow
determination of the appropriate enzyme amount for protein digestion. Incomplete protein
digestion can lead to generation of low abundance peptides which will not be selected for
fragmentation during data-dependent acquisition mode or, if selected, will result in low MS/
MS spectra quality. Longer reaction times (> 30 min) under microwave-assisted digestion,62
addition of organic solvents, surfactants and chaotropes to increase protein solubilization
and denaturation,61,63 and use of the optimum enzyme pH range during digestion64 have all
been shown to enhance completeness of the digestion. It is important to note that
considerable attention should be given to addition of surfactants and chaotropes as these
may interfere with LC-MS and therefore need to be removed prior to LC-MS analysis (see
discussion below).
Unspecific cleavages refer to peptides, whose termini do not contain the expected amino
acid derived from specific protease cleavage. These may arise from protease impurities,
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contamination with other proteases and nonspecific proteolysis during sample preparation.65
In addition, incubation time, digestion buffers, digestion temperature,65 and enzyme to
protein ratio,66 have also been shown to affect enzyme specificity. Recently, the specificity
of Glu-C, chymotrypsin and CNBr digestion was assessed by Pevzner and coworkers using
Shewanella oneidensis as the model system and the frequency of unspecific cleavages was
reported and evaluated.67 The proteolytic cleavage specificity of Lys-C and Lys-N was also
examined by digesting HEK293 cell lysates under optimized digestion conditions.68 The
authors reported 90% enzyme specificity for Lys-C and 72% for Lys-N.68
Trypsin has gained popularity in proteomics not only due to its high specificity but also due
to the generation of suitable size peptides (10–15 amino acids residues long) for MS
analysis, and the fact that tryptically digested peptides produce doubly charged precursor
ions, which fragment efficiently in CID.61,64,69 Several protocols have been developed to
improve and enhance trypsin digestion using the addition of denaturation and solubilization
agents, high hydrostatic pressure, immobilized enzymes, infrared irradiation and microwave
irradiation.63,64,70–81 In addition, the cleavage specificity, efficiency and reproducibility of
several different types of commercially available trypsin were evaluated.82 The authors
concluded that the sequencing grade modified trypsin from Promega provided optimal
results.82 Double digestion, Lys-C digestion followed by trypsin digestion, is very common
in proteomics especially in cases in which high concentration of urea ∼8 M is used for
proteins denaturation. Trypsin has a reduced activity at 8 M urea, whereas Lys-C retains its
activity at 8 M urea. Before trypsin addition, urea concentration is diluted to 2 M. This
treatment generally results in good sequence coverage with limited missed cleavages.
In addition to urea, SDS is also widely used for protein denaturation and solubilization. An
acid labile detergent, RapiGest SF,83 is also gaining popularity in proteomics sample
preparation as it can be easily removed from the sample and it is compatible with proteolytic
enzymes. An increase in protein identifications has been reported in the presence of
RapiGest SF versus other commonly employed detergents.42,63 Additionally, the
performance of three commercially available MS compatible surfactants (Invitrosol, PPS
silent surfactant and RapiGest SF) was evaluated in both aqueous and organic-aqueous
digestion solutions.84
Identification rates and proteome sequence coverage can be improved by the use of multiple
proteases with varying specificity, as it was illustrated for the yeast proteome85 and
plasma.86 Further increase in proteome coverage can be obtained by sample fractionation
followed by a second dimension separation achieved by LC-MS/MS analysis of each
individual fraction. Pre-fractionation reduces sample complexity and consequently decreases
undersampling during LC-MS/MS analysis as fewer analytes are simultaneously introduced
into the mass spectrometer.87 Pre-fractionation techniques should preferentially be
orthogonal to reversed phase chromatography as the latter is usually employed for on-line
LC separation. Several chromatographic and electrophoretic approaches are used for sample
pre-fractionation,87–89 such as SDS page, strong cation exchange, strong anion exchange,
hydrophilic interaction, and isoelectric focusing, The performance of different pre-
fractionation techniques in terms of proteome coverage and reproducibility has been
previously evaluated for a wide range of samples.19,90–94 It is important to note that the
effectiveness of the fractionation technique will be largely dependent on the nature of the
sample. Furthermore, it should be pointed out that pre-fractionation reduces sample
throughput, but at the same time improved proteome coverage is achieved.
Sample cleanup is another factor that needs to be considered for obtaining high quality
proteomics data. Salts, buffers and detergent contaminants, such as Tris•HCl, NaCl, urea
and sodium dodecyl sulfate (SDS) interfere with the LC-MS/MS analysis, causing column
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clogging, decreasing quality of MS and MS/MS spectra, reducing ESI sensitivity due to ion
suppression, and therefore avoidance and/or removal prior to analysis is a prerequisite for a
successful experimental outcome.95 A protocol that allows fast cleanup of samples
containing salts, detergents and buffers has been developed.96,97 This protocol utilizes spin
filter devices for digestion to allow resuspension of proteins in buffers compatible with
digestion and removal of detergents or salts prior to MS analysis.96,97 In agreement with
these reports we also observed that digestion utilizing spin filter resulted in higher
identification rates compared to conventional in-solution digestion. Recently, Bereman et.al.
introduced the use of self-packed spin columns to effectively remove SDS from complex
proteomics samples (Saccharomyces cerevisiae, Caenorhabditis elegans lysate and
HEK293T cells), prior to LC-MS/MS analysis.98 Efficient removal of a wide range of
commonly used detergents in proteomic, including SDS, CHAPS, lauryl maltoside, octyl
and glucoside, was demonstrated for a commercially available spin column.99 Alternatively,
offline LC purification can be used for sample cleanup, allowing for independent UV
quantification of the sample.95
Further discussion on methodologies and strategies for sample preparation in proteomics as
well as advantages and disadvantages associated with these methods can be found in
previously published reports.51,64,69,76 In addition, available digestion techniques as well as
recent developments to accelerate the digestion step have been very recently reviewed and
discussed in details by Switzar et.al.54 Approaches specifically designed for certain protein
classes, which are difficult to analyze with conventional digestion approached, were also
presented.54
In addition to the MS data acquisition and sample preparation, LC performance is also
important in proteomics analysis. The performance of the LC system can be affected by the
column material, improper fluidic connections, leakages or blockages in the system, flow
rate,10 elution gradient and length,10 sample loading amount,9,10 sample loading
conditions11 and sample carryover.100 Optimization and evaluation of several of these
parameters have been previously performed.9–11,100 It has been demonstrated that sample
loading amount affects the identification rates9,10 and that the optimal gradient length
depends on the amount of sample loaded.10 In addition it was shown that sample loading
conditions can affect identification rates depending on the column packing material used for
the analysis.11 Optimal flow rates and elution gradient also lead to higher identification
rates.10 In agreement with these observations we also observed an increase in identifications
by optimizing the LC-gradient, column material and sample loading amount.
Given the very large amount of data generated in MS-based proteomics experiments, peptide
and protein identification is almost exclusively performed through automated database
searching. Several database search algorithms, including Mascot,101 X!Tandem,102
OMSSA,103 Sequest,104 Andromeda,105 and ROCCIT (roccit.caltech.edu) are available for
translating MS/MS spectra into peptides sequences. In our laboratory, due to its advanced
signaling processing capabilities for Thermo raw files, we generally use MaxQuant for
quantitative bottom-up data analysis.
The general principle of most search engines is the selection of candidate peptides from the
sequence database whose theoretical masses match the experimental masses determined
from the MS spectra. For each candidate peptide a theoretical MS/MS spectrum is created
and compared to the experimental MS/MS spectrum to calculate a similarity score between
the two spectra and the top scoring peptide is reported.106–110
Due to the widespread use and critical role of database search algorithms in proteomics,
several reports have focused on systematic evaluation and comparison of frequently used
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search engines,106,111 performance of search algorithms under different mass tolerance
settings,107 and description of the rationale and basic concepts used by database search
tools.108,112,113 In addition, considerations and recommendations regarding the search
parameters, search strategy, protein sequence database used, chosen search engine,108,113,114
and data interpretation115 have been reviewed.
A major challenge of automated database searching is to ensure high confidence peptide and
protein identifications since the top scoring peptide assigned by the search engines does not
always represent the correct identification.107–111,116–118 A widely used method to assess
the confidence in the set of peptide identifications for large-scale data sets is the use of false
discovery rate. False discovery rate (FDR) is an estimation of the number of incorrect
identifications among all accepted assignments and allows data filtering by selecting a
desired FDR cutoff. A commonly used strategy for evaluating FDRs is the target decoy
approach.119 The use and compatibility of target decoy approach with several popular
database search tools has been recently discussed and reevaluated by Pevzner and
coworkers.120
CONCLUSIONS
In this tutorial we have described and discussed important MS and MS/MS settings widely
employed during DDA mode on LTQ-Orbitrap mass analyzers. We presented recommended
values for these data-dependent settings determined by systematic investigation and
evaluation. 13–16 Data from the Orbitrap Classic, XL, and the newly introduced Orbitrap
Elite was presented. While several settings are easily transferable to the Orbitrap Elite from
the previous generation Orbitrap mass analyzers, others needed to be reexamined and
reevaluated. Discussion on the Q Exactive and HCD was also given. In addition, sample
preparation, LC optimization and bioinformatics analysis, which are also vital for a
successful proteomics experiment, were also discussed. The discussion presented here,
strongly suggests that by optimizing sample preparation, MS and LC instruments
performance and bioinformatics analysis, significantly improved analysis of complex
proteomic samples can be achieved. We hope that this tutorial will provide useful insights
into understanding and optimizing important variables for shotgun proteomics experiments.
Acknowledgments
We thank Tonya P. Second, Rolly Singh, Anjum A. Khan and Martin Zeller at Thermo Fisher Scientific for their
valuable discussions and help. The Proteome Exploration Laboratory is supported by the Gordon and Betty Moore
Foundation through Grant GBMF775, the Beckman Institute and an instrumentation grant from NIH (10565784).
REFERENCES
1. Stahl DC, Swiderek KM, Davis MT, Lee TD. Data-controlled automation of liquid chromatography
tandem mass spectrometry analysis of peptide mixtures. J. Am. Soc. Mass Spectrom. 1996; 7(6):
532–540.
2. Makarov A, Denisov E, Kholomeev A, Baischun W, Lange O, Strupat K, Horning S. Performance
evaluation of a hybrid linear ion trap/orbitrap mass spectrometer. Anal. Chem. 2006; 78(7):2113–
2120. [PubMed: 16579588]
3. Yates JR, Cociorva D, Liao LJ, Zabrouskov V. Performance of a linear ion trap-orbitrap hybrid for
peptide analysis. Anal. Chem. 2006; 78(2):493–500. [PubMed: 16408932]
4. Scigelova M, Hornshaw M, Giannakopulos A, Makarov A. Fourier transform mass spectrometry.
Mol. Cell. Proteomics. 2011; 10(7):1–19.
5. Perry RH, Cooks RG, Noll RJ. Orbitrap mass spectrometry: instrumentation, ion motion and
applications. Mass Spectrom. Rev. 2008; 27(6):661–699. [PubMed: 18683895]
Kalli et al. Page 16
J Proteome Res. Author manuscript; available in PMC 2014 July 05.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
6. Hu QZ, Noll RJ, Li HY, Makarov A, Hardman M, Cooks RG. The Orbitrap: a new mass
spectrometer. J. Mass Spectrom. 2005; 40(4):430–443. [PubMed: 15838939]
7. Makarov A. Electrostatic axially harmonic orbital trapping: A high-performance technique of mass
analysis. Anal. Chem. 2000; 72(6):1156–1162. [PubMed: 10740853]
8. Hardman M, Makarov AA. Interfacing the orbitrap mass analyzer to an electrospray ion source.
Anal. Chem. 2003; 75(7):1699–1705. [PubMed: 12705605]
9. Liu KH, Zhang JY, Wang JL, Zhao LY, Peng X, Jia W, Ying WT, Zhu YP, Xie HW, He FC, Qian
XH. Relationship between sample loading amount and peptide identification and Its effects on
quantitative proteomics. Anal. Chem. 2009; 81(4):1307–1314. [PubMed: 19146458]
10. Xu P, Duong DM, Peng JM. Systematical optimization of reverse-phase chromatography for
shotgun proteomics. J. Proteome Res. 2009; 8(8):3944–3950. [PubMed: 19566079]
11. Peterson A, Hohmann L, Huang L, Kim B, Eng JK, Martin DB. Analysis of RP-HPLC loading
conditions for maximizing peptide identifications in shotgun proteomics. J. Proteome Res. 2009;
8(8):4161–4168. [PubMed: 19601632]
12. Zhang Y, Wen ZH, Washburn MP, Florens L. Effect of dynamic exclusion duration on spectral
count based quantitative proteomics. Anal. Chem. 2009; 81(15):6317–6326. [PubMed: 19586016]
13. Andrews GL, Dean RA, Hawkridge AM, Muddiman DC. Improving proteome coverage on a
LTQ-Orbitrap using design of experiments. J. Am. Soc. Mass Spectrom. 2011; 22(4):773–783.
[PubMed: 21472614]
14. Wong CCL, Cociorva D, Venable JD, Xu T, Yates JR. Comparison of different signal thresholds
on data dependent sampling in Orbitrap and LTQ mass spectrometry for the identification of
peptides and proteins in complex mixtures. J. Am. Soc. Mass Spectrom. 2009; 20(8):1405–1414.
[PubMed: 19467883]
15. Kim MS, Kandasamy K, Chaerkady R, Pandey A. Assessment of resolution parameters for CID-
based shotgun proteomic experiments on the LTQ-Orbitrap mass spectrometer. J. Am. Soc. Mass
Spectrom. 2010; 21(9):1606–1611. [PubMed: 20483638]
16. Kalli A, Hess S. Effect of mass spectrometric parameters on peptide and protein identification rates
for shotgun proteomic experiments on an LTQ-orbitrap mass analyzer. Proteomics. 2012; 12(1):
21–31. [PubMed: 22065615]
17. Riter LS, Vitek O, Gooding KM, Hodge BD, Julian RK. Statistical design of experiments as a tool
in mass spectrometry. J. Mass Spectrom. 2005; 40(5):565–579. [PubMed: 15880604]
18. Sweredoski JM, Smith TG, Kalli A, Graham LJR, Hess S. LogViewer: A software tool to visualize
quality control parameters to optimize proteomics experiments using Orbitrap and LTQ-FT mass
spectrometers. J. Biomol. Tech. 2011; 22(4):122–126. [PubMed: 22131886]
19. Slebos RJC, Brock JWC, Winters NF, Stuart SR, Martinez MA, Li M, Chambers MC, Zimmerman
LJ, Ham AJ, Tabb DL, Liebler DC. Evaluation of strong cation exchange versus isoelectric
focusing of peptides for multidimensional liquid chromatography-tandem mass spectrometry. J.
Proteome Res. 2008; 7(12):5286–5294. [PubMed: 18939861]
20. Mesmin C, Fenaille F, Becher F, Tabet J-C, Ezan E. Identification and characterization of apelin
peptides in bovine colostrum and milk by liquid chromatography-mass spectrometry. J. Proteome
Res. 2011; 10(11):5222–31. [PubMed: 21939284]
21. Scherl A, Shaffer SA, Taylor GK, Hernandez P, Appel RD, Binz PA, Goodlett DR. On the benefits
of acquiring peptide fragment ions at high measured mass accuracy. J. Am. Soc. Mass Spectrom.
2008; 19(6):891–901. [PubMed: 18417358]
22. Yu L, Tan Y, Tsai Y, Goodlett DR, Polfer NC. On the relevance of peptide sequence permutations
in shotgun proteomics studies. J. Proteome Res. 2011; 10(5):2409–2416. [PubMed: 21413817]
23. Nagaraj N, Mann M. Quantitative analysis of the intra- and inter-individual variability of the
normal urinary proteome. J. Proteome Res. 2010; 10(2):637–645. [PubMed: 21126025]
24. Poliakov A, Russell CW, Ponnala L, Hoops HJ, Sun Q, Douglas AE, van Wijk KJ. Large-scale
label-free quantitative proteomics of the pea aphid-buchnera symbiosis. Mol. Cell. Proteomics.
2011; 10(6)
25. Michalski A, Cox J, Mann M. More than 100,000 detectable peptide species elute in single shotgun
proteomics runs but the majority is inaccessible to data-dependent LC-MS/MS. J. Proteome Res.
2011; 10(4):1785–1793. [PubMed: 21309581]
Kalli et al. Page 17
J Proteome Res. Author manuscript; available in PMC 2014 July 05.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
26. Lu B, Motoyama A, Ruse C, Venable J, Yates JR III. Improving protein identification sensitivity
by combining MS and MS/MS information for shotgun proteomics using LTQ-Orbitrap high mass
accuracy data. Anal. Chem. 2008; 80(6):2018–2025. [PubMed: 18275164]
27. Gokce E, Andrews GL, Dean RA, Muddiman DC. Increasing proteome coverage with offline RP
HPLC coupled to online RP nanoLC-MS. J. Chromatogr. B. 2011; 879(9–10):610–614.
28. Tayo LL, Lu B, Cruz LJ, Yates JR III. Proteomic analysis provides insights on venom processing
in Conus textile. J. Proteome Res. 2010; 9(5):2292–2301. [PubMed: 20334424]
29. Frese CK, Altelaar AFM, Hennrich ML, Nolting D, Zeller M, Griep-Raming J, Heck AJR,
Mohammed S. Improved peptide identification by targeted fragmentation using CID, HCD and
ETD on an LTQ-Orbitrap Velos. J. Proteome Res. 2011; 10(5):2377–2388. [PubMed: 21413819]
30. Olsen JV, Schwartz JC, Griep-Raming J, Nielsen ML, Damoc E, Denisov E, Lange O, Remes P,
Taylor D, Splendore M, Wouters ER, Senko M, Makarov A, Mann M, Horning S. A dual pressure
linear ion trap Orbitrap instrument with very high sequencing speed. Mol. Cell. Proteomics. 2009;
8(12):2759–2769. [PubMed: 19828875]
31. Hahne H, Wolff S, Hecker M, Becher D. From complementarity to comprehensiveness - targeting
the membrane proteome of growing Bacillus subtilis by divergent approaches. Proteomics. 2008;
8(19):4123–4136. [PubMed: 18763711]
32. Thakur SS, Geiger T, Chatterjee B, Bandilla P, Frohlich F, Cox J, Mann M. Deep and highly
sensitive proteome coverage by LC-MS/MS without prefractionation. Mol. Cell. Proteomics.
2011; 10(8)
33. Makawita S, Smith C, Batruch I, Zheng YY, Ruckert F, Grutzmann R, Pilarsky C, Gallinger S,
Diamandis EP. Integrated proteomic profiling of cell line conditioned media and pancreatic juice
for the identification of pancreatic cancer biomarkers. Mol. Cell. Proteomics. 2011; 10(10)
34. Adachi J, Kumar C, Zhang YL, Olsen JV, Mann M. The human urinary proteome contains more
than 1500 proteins, including a large proportion of membrane proteins. Genome Biol. 2006;
7(9):R72. [PubMed: 16901338]
35. de Souza GA, Godoy LMF, Mann M. Identification of 491 proteins in the tear fluid proteome
reveals a large number of proteases and protease inhibitors. Genome Biol. 2006; 7(8):R80.
[PubMed: 16948836]
36. Michalski A, Damoc E, Lange O, Denisov E, Nolting D, Muller M, Viner R, Schwartz J, Remes P,
Belford M, Dunyach JJ, Cox J, Horning S, Mann M, Makarov A. Ultra high resolution linear ion
trap Orbitrap mass spectrometer (Orbitrap Elite) facilitates top down LC MS/MS and versatile
peptide fragmentation modes. Mol. Cell. Proteomics. 2012; 11(3)
37. Ghaemmaghami S, Huh W, Bower K, Howson RW, Belle A, Dephoure N, O'Shea EK, Weissman
JS. Global analysis of protein expression in yeast. Nature. 2003; 425(6959):737–741. [PubMed:
14562106]
38. Michalski A, Damoc E, Hauschild JP, Lange O, Wieghaus A, Makarov A, Nagaraj N, Cox J, Mann
M, Horning S. Mass Spectrometry-based Proteomics Using Q Exactive, a High-performance
Benchtop Quadrupole Orbitrap Mass Spectrometer. Mol. Cell. Proteomics. 2011; 10(9)
39. Kelstrup CD, Young C, Lavallee R, Nielsen ML, Olsen JV. Optimized fast and sensitive
acquisition methods for shotgun proteomics on a quadrupole orbitrap mass spectrometer. J.
Proteome Res. 2012; 11(6):3487–3497.
40. Nagaraj N, Kulak NA, Cox J, Neuhauser N, Mayr K, Hoerning O, Vorm O, Mann M. System-wide
Perturbation Analysis with Nearly Complete Coverage of the Yeast Proteome by Single-shot Ultra
HPLC Runs on a Bench Top Orbitrap. Mol. Cell. Proteomics. 2012; 11(3)
41. Sun LL, Zhu GJ, Dovichi NJ. Comparison of the LTQ-Orbitrap Velos and the Q-Exactive for
proteomic analysis of 1–1000 ng RAW 264.7 cell lysate digests. Rapid Commun. Mass Spectrom.
2013; 27(1):157–162. [PubMed: 23239329]
42. Winter D, Steen H. Optimization of cell lysis and protein digestion protocols for the analysis of
HeLa S3 cells by LC-MS/MS. Proteomics. 2011; 11(24):4726–4730. [PubMed: 22002805]
43. Beltran L, Cutillas PR. Advances in phosphopeptide enrichment techniques for
phosphoproteomics. Amino Acids. 2012; 43(3):1009–1024. [PubMed: 22821267]
44. Thingholm TE, Jensen ON, Larsen MR. Analytical strategies for phosphoproteomics. Proteomics.
2009; 9(6):1451–1468. [PubMed: 19235172]
Kalli et al. Page 18
J Proteome Res. Author manuscript; available in PMC 2014 July 05.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
45. Eyrich B, Sickmann A, Zahedi RP. Catch me if you can: Mass spectrometry-based
phosphoproteomics and quantification strategies. Proteomics. 2011; 11(4):554–570. [PubMed:
21226000]
46. Faca V, Pitteri SJ, Newcomb L, Glukhova V, Phanstiel D, Krasnoselsky A, Zhang Q, Struthers J,
Wang H, Eng J, Fitzgibbon M, McIntosh M, Hanash S. Contribution of protein fractionation to
depth of analysis of the serum and plasma proteomes. J. Proteome Res. 2007; 6(9):3558–3565.
[PubMed: 17696519]
47. Nagaraj N, Lu AP, Mann M, Wisniewski JR. Detergent-based but Gel-free method allows
identification of several hundred membrane proteins in single LC-MS runs. J. Proteome Res. 2008;
7(11):5028–5032. [PubMed: 18839980]
48. Fila J, Honys D. Enrichment techniques employed in phosphoproteomics. Amino Acids. 2012;
43(3):1025–1047. [PubMed: 22002794]
49. Helbig AO, Heck AJR, Slijper M. Exploring the membrane proteome-Challenges and analytical
strategies. J. Proteomics. 2010; 73(5):868–878. [PubMed: 20096812]
50. Pan S, Chen R, Aebersold R, Brentnall TA. Mass spectrometry based glycoproteomics-from a
proteomics perspective. Mol. Cell. Proteomics. 2011; 10(1)
51. Bodzon-Kulakowska A, Bierczynska-Krzysik A, Dylag T, Drabik A, Suder P, Noga M,
Jarzebinska J, Silberring J. Methods for sample preparation in proteomic research. J. Chromatogr.
B-Analytical Technologies in the Biomedical and Life Sciences. 2007; 849(1–2):1–31.
52. Wang FJ, Song CX, Cheng K, Jiang XN, Ye ML, Zou HF. Perspectives of comprehensive
phosphoproteome analysis using shotgun strategy. Anal. Chem. 2011; 83(21):8078–8085.
[PubMed: 21928789]
53. Tichy A, Salovska B, Rehulka P, Klimentova J, Vavrova J, Stulik J, Hernychova L.
Phosphoproteomics: Searching for a needle in a haystack. J. Proteomics. 2011; 74(12):2786–2797.
[PubMed: 21839867]
54. Switzar L, Giera M, Niessen MAW. Protein digestion: An overview of the available techniques
and recent developments. J. Proteome Res. 2013; 12(3):1067–1077. [PubMed: 23368288]
55. Sprenger RR, Jensen ON. Proteomics and the dynamic plasma membrane: Quo Vadis? Proteomics.
2010; 10(22):3997–4011. [PubMed: 21080491]
56. Proc JL, Kuzyk MA, Hardie DB, Yang J, Smith DS, Jackson AM, Parker CE, Borchers CH. A
Quantitative Study of the Effects of Chaotropic Agents, Surfactants, and Solvents on the Digestion
Efficiency of Human Plasma Proteins by Trypsin. J. Proteome Res. 2010; 9(10):5422–5437.
[PubMed: 20722421]
57. Callesen AK, Madsen JS, Vach W, Kruse TA, Mogensen O, Jensen ON. Serum protein profiling
by solid phase extraction and mass spectrometry: A future diagnostics tool? Proteomics. 2009;
9(6):1428–1441. [PubMed: 19235169]
58. Bladergroen MR, Derks RJE, Nicolardi S, de Visser B, van Berloo S, van der Burgt YEM, Deelder
AM. Standardized and automated solid-phase extraction procedures for high-throughput
proteomics of body fluids. J. Proteomics. 2012; 77:144–153. [PubMed: 22842157]
59. Cordwell SJ, Thingholm TE. Technologies for plasma membrane proteomics. Proteomics. 2010;
10(4):611–627. [PubMed: 19834916]
60. Leitner A, Sturm M, Lindner W. Tools for analyzing the phosphoproteome and other
phosphorylated biomolecules: A review. Anal. Chim. Acta. 2011; 703(1):19–30. [PubMed:
21843671]
61. Brownridge P, Beynon RJ. The importance of the digest: Proteolysis and absolute quantification in
proteomics. Methods. 2011; 54(4):351–360. [PubMed: 21683145]
62. Reddy PM, Hsu WY, Hu JF, Ho YP. Digestion completeness of microwave-assisted and
conventional trypsin-catalyzed reactions. J. Am. Soc. Mass Spectrom. 2010; 21(3):421–424.
[PubMed: 20044269]
63. Klammer AA, MacCoss MJ. Effects of modified digestion schemes on the identification of
proteins from complex mixtures. J. Proteome Res. 2006; 5(3):695–700. [PubMed: 16512685]
64. Capelo JL, Carreira R, Diniz M, Fernandes L, Galesio M, Lodeiro C, Santos HM, Vale G.
Overview on modern approaches to speed up protein identification workflows relying on
Kalli et al. Page 19
J Proteome Res. Author manuscript; available in PMC 2014 July 05.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
enzymatic cleavage and mass spectrometry-based techniques. Anal. Chim. Acta. 2009; 650(2):
151–159. [PubMed: 19720186]
65. Lubec G, Afjehi-Sadat L. Limitations and pitfalls in protein identification by mass spectrometry.
Chem. Rev. 2007; 107(8):3568–3584. [PubMed: 17645314]
66. Hara S, Rosenfeld R, Lu HS. Preventing the generation of artifacts during peptide map analysis of
recombinant human insulin-like growth factor-I. Anal. Biochem. 1996; 243(1):74–79. [PubMed:
8954527]
67. Gupta N, Hixson KK, Culley DE, Smith RD, Pevzner PA. Analyzing protease specificity and
detecting in vivo proteolytic events using tandem mass spectrometry. Proteomics. 2010; 10(15):
2833–2844. [PubMed: 20597098]
68. Raijmakers R, Neerincx P, Mohammed S, Heck AJR. Cleavage specificities of the brother and
sister proteases Lys-C and Lys-N. Chem. Commun. 2010; 46(46):8827–8829.
69. Canas B, Pineiro C, Calvo E, Lopez-Ferrer D, Gallardo JM. Trends in sample preparation for
classical and second generation proteomics. J. Chromatogr. A. 2007; 1153(1–2):235–258.
[PubMed: 17276441]
70. Vaezzadeh AR, Deshusses JMP, Waridel P, Francois P, Zimmermann-Ivol CG, Lescuyer P,
Schrenzel J, Hochstrasser DF. Accelerated digestion for high-throughput proteomics analysis of
whole bacterial proteomes. J. Microbiol. Meth. 2010; 80(1):56–62.
71. Hervey WJ, Strader MB, Hurst GB. Comparison of digestion protocols for microgram quantities of
enriched protein samples. J. Proteome Res. 2007; 6(8):3054–3061. [PubMed: 17616116]
72. Massolini G, Calleri E. Immobilized trypsin systems coupled on-line to separation methods:
Recent developments and analytical applications. J. Sep. Science. 2005; 28(1):7–21.
73. Wang S, Zhang LY, Yang PY, Chen G. Infrared-assisted tryptic proteolysis for peptide mapping.
Proteomics. 2008; 8(13):2579–2582. [PubMed: 18546161]
74. Sun W, Gao SJ, Wang LJ, Chen Y, Wu SZ, Wang XR, Zheng DX, Gao YH. Microwave-assisted
protein preparation and enzymatic digestion in proteomics. Mol. Cell. Proteomics. 2006; 5(4):769–
776. [PubMed: 16339992]
75. Ye XX, Li L. Microwave-assisted protein solubilization for mass spectrometry-based shotgun
proteome analysis. Anal. Chem. 2012; 84(14):6181–6191. [PubMed: 22708679]
76. Lill JR, Ingle ES, Liu PS, Pham V, Sandoval WN. Microwave-assisted proteomics. Mass
Spectrom. Rev. 2007; 26(5):657–671. [PubMed: 17474122]
77. Pramanik BN, Mirza UA, Ing YH, Liu YH, Bartner PL, Weber PC, Bose MK. Microwave-
enhanced enzyme reaction for protein mapping by mass spectrometry: A new approach to protein
digestion in minutes. Protein Sci. 2002; 11(11):2676–2687. [PubMed: 12381849]
78. Freeman E, Ivanov AR. Proteomics under pressure: development of essential sample preparation
techniques in proteomics using ultrahigh hydrostatic pressure. J. Proteome Res. 2011; 10(12):
5536–5546. [PubMed: 22029901]
79. Lee B, Lopez-Ferrer D, Kim BC, Bin Na H, Il Park Y, Weitz KK, Warner MG, Hyeon T, Lee SW,
Smith RD, Kim J. Rapid and efficient protein digestion using trypsin-coated magnetic
nanoparticles under pressure cycles. Proteomics. 2011; 11(2):309–318. [PubMed: 21204257]
80. Dycka F, Bobal P, Mazanec K, Bobalova J. Rapid and efficient protein enzymatic digestion: An
experimental comparison. Electrophoresis. 2012; 33(2):288–295. [PubMed: 22170586]
81. Duan JC, Liang Z, Yang C, Zhang J, Zhang LH, Zhang WB, Zhang YK. Rapid protein
identification using monolithic enzymatic microreactor and LC-ESI-MS/MS. Proteomics. 2006;
6(2):412–419. [PubMed: 16342240]
82. Burkhart JM, Schumbrutzki C, Wortelkamp S, Sickmann A, Zahedi RP. Systematic and
quantitative comparison of digest efficiency and specificity reveals the impact of trypsin quality on
MS-based proteomics. J. Proteomics. 2012; 75(4):1454–1462. [PubMed: 22166745]
83. Yu YQ, Gilar M, Lee PJ, Bouvier ESP, Gebler JC. Enzyme-friendly, mass spectrometry-
compatible surfactant for in-solution enzymatic digestion of proteins. Anal. Chem. 2003; 75(21):
6023–6028. [PubMed: 14588046]
84. Chen EI, Cociorva D, Norris JL, Yates JR. Optimization of mass spectrometry-compatible
surfactants for shotgun proteomics. J. Proteome Res. 2007; 6(7):2529–2538. [PubMed: 17530876]
Kalli et al. Page 20
J Proteome Res. Author manuscript; available in PMC 2014 July 05.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
85. Swaney DL, Wenger CD, Coon JJ. Value of using multiple proteases for large-scale mass
spectrometry-based proteomics. J. Proteome Res. 2010; 9(3):1323–1329. [PubMed: 20113005]
86. Choudhary G, Wu SL, Shieh P, Hancock WS. Multiple enzymatic digestion for enhanced sequence
coverage of proteins in complex proteomic mixtures using capillary LC with ion trap MS/MS. J.
Proteome Res. 2003; 2(1):59–67. [PubMed: 12643544]
87. Angel TE, Aryal UK, Hengel SM, Baker ES, Kelly RT, Robinson EW, Smith RD. Mass
spectrometry-based proteomics: existing capabilities and future directions. Chem. Soc. Rev. 2012;
41(10):3912–3928. [PubMed: 22498958]
88. Selvaraju S, El Rassi Z. Liquid-phase-based separation systems for depletion, prefractionation and
enrichment of proteins in biological fluids and matrices for in-depth proteomics analysis - An
update covering the period 2008–2011. Electrophoresis. 2012; 33(1):74–88. [PubMed: 22125262]
89. Ly L, Wasinger VC. Protein and peptide fractionation, enrichment and depletion: Tools for the
complex proteome. Proteomics. 2011; 11(4):513–534. [PubMed: 21241016]
90. Manadas B, English JA, Wynne KJ, Cotter DR, Dunn MJ. Comparative analysis of OFFGel, strong
cation exchange with pH gradient, and RP at high pH for first-dimensional separation of peptides
from a membrane-enriched protein fraction. Proteomics. 2009; 9(22):5194–5198. [PubMed:
19771557]
91. Wang H, Chang-Wong T, Tang HY, Speicher DW. Comparison of extensive protein fractionation
and repetitive LC-MS/MS analyses on depth of analysis for complex proteomes. J. Proteome Res.
2010; 9(2):1032–1040. [PubMed: 20014860]
92. Dowell JA, Frost DC, Zhang J, Li LJ. Comparison of two-dimensional fractionation techniques for
shotgun proteomics. Anal. Chem. 2008; 80(17):6715–6723. [PubMed: 18680313]
93. Whiteaker JR, Zhang HD, Eng JK, Fang RH, Piening BD, Feng LC, Lorentzen TD, Schoenherr
RM, Keane JF, Holzman T, Fitzgibbon M, Lin CW, Zhang H, Cooke K, Liu T, Camp DG,
Anderson L, Watts J, Smith RD, McIntosh MW, Paulovich AG. Head-to-head comparison of
serum fractionation techniques. J. Proteome Res. 2007; 6(2):828–836. [PubMed: 17269739]
94. Wang YX, Yang F, Gritsenko MA, Wang YC, Clauss T, Liu T, Shen YF, Monroe ME, Lopez-
Ferrer D, Reno T, Moore RJ, Klemke RL, Camp DG, Smith RD. Reversed-phase chromatography
with multiple fraction concatenation strategy for proteome profiling of human MCF10A cells.
Proteomics. 2011; 11(10):2019–2026. [PubMed: 21500348]
95. Graham RLJ, Kalli A, Smith GT, Sweredoski MJ, Hess S. Avoiding Pitfalls in Proteomics Sample
Preparation. Biomacromolecular Mass Spectrometry. 2011; 2(4):261–271.
96. Manza LL, Stamer SL, Ham AJL, Codreanu SG, Liebler DC. Sample preparation and digestion for
proteomic analyses using spin filters. Proteomics. 2005; 5(7):1742–1745. [PubMed: 15761957]
97. Wisniewski JR, Zougman A, Nagaraj N, Mann M. Universal sample preparation method for
proteome analysis. Nat. Methods. 2009; 6(5):359–U60. [PubMed: 19377485]
98. Bereman MS, Egertson JD, MacCoss MJ. Comparison between procedures using SDS for shotgun
proteomic analyses of complex samples. Proteomics. 2011; 11(14):2931–2935. [PubMed:
21656683]
99. Antharavally BS, Mallia KA, Rosenblatt MM, Salunkhe AM, Rogers JC, Haney P, Haghdoost N.
Efficient removal of detergents from proteins and peptides in a spin column format. Anal.
Biochem. 2011; 416(1):39–44. [PubMed: 21640699]
100. Mitulovic G, Stingl C, Steinmacher I, Hudecz O, Hutchins JRA, Peters JM, Mechtler K.
Preventing carryover of peptides and proteins in nano LC-MS separations. Anal. Chem. 2009;
81(14):5955–5960. [PubMed: 19537771]
101. Perkins DN, Pappin DJC, Creasy DM, Cottrell JS. Probability-based protein identification by
searching sequence databases using mass spectrometry data. Electrophoresis. 1999; 20(18):3551–
3567. [PubMed: 10612281]
102. Craig R, Beavis RC. TANDEM: matching proteins with tandem mass spectra. Bioinformatics.
2004; 20(9):1466–1467. [PubMed: 14976030]
103. Geer LY, Markey SP, Kowalak JA, Wagner L, Xu M, Maynard DM, Yang XY, Shi WY, Bryant
SH. Open mass spectrometry search algorithm. J. Proteome Res. 2004; 3(5):958–964. [PubMed:
15473683]
Kalli et al. Page 21
J Proteome Res. Author manuscript; available in PMC 2014 July 05.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
104. Eng JK, McCormack AL, Yates JR. An approach to correlate tandem mass-spectral data of
peptides with amino-acid-sequences in a protein database. J. Am. Soc. Mass Spectrom. 1994;
5(11):976–989.
105. Cox J, Neuhauser N, Michalski A, Scheltema RA, Olsen JV, Mann M. Andromeda: A peptide
search engine integrated into the MaxQuant environment. J. Proteome Res. 2011; 10(4):1794–
1805. [PubMed: 21254760]
106. Balgley BM, Laudeman T, Yang L, Song T, Lee CS. Comparative evaluation of tandem MS
search algorithms using a target-decoy search strategy. Mol. Cell. Proteomics. 2007; 6(9):1599–
1608. [PubMed: 17533222]
107. Brosch M, Swamy S, Hubbard T, Choudhary J. Comparison of Mascot and X!Tandem
performance for low and high accuracy mass spectrometry and the development of an adjusted
Mascot threshold. Mol. Cell. Proteomics. 2008; 7(5):962–970. [PubMed: 18216375]
108. Eng JK, Searle BC, Clauser KR, Tabb DL. A face in the crowd: Recognizing peptides through
database search. Mol. Cell. Proteomics. 2011; 10(11)
109. Nesvizhskii AI, Vitek O, Aebersold R. Analysis and validation of proteomic data generated by
tandem mass spectrometry. Nat. Methods. 2007; 4(10):787–797. [PubMed: 17901868]
110. Deutsch EW, Lam H, Aebersold R. Data analysis and bioinformatics tools for tandem mass
spectrometry in proteomics. Physiol. Genomics. 2008; 33(1):18–25. [PubMed: 18212004]
111. Kapp EA, Schutz F, Connolly LM, Chakel JA, Meza JE, Miller CA, Fenyo D, Eng JK, Adkins
JN, Omenn GS, Simpson RJ. An evaluation, comparison, and accurate benchmarking of several
publicly available MS/MS search algorithms: Sensitivity and specificity analysis. Proteomics.
2005; 5(13):3475–3490. [PubMed: 16047398]
112. Sadygov RG, Cociorva D, Yates JR. Large-scate database searching using tandem mass spectra:
Looking up the answer in the back of the book. Nat. Methods. 2004; 1(3):195–202. [PubMed:
15789030]
113. Matthiesen R. Methods, algorithms and tools in computational proteomics: A practical point of
view. Proteomics. 2007; 7(16):2815–2832. [PubMed: 17703506]
114. Nesvizhskii AI, Aebersold R. Analysis, statistical validation and dissemination of large-scale
proteomics datasets generated by tandem MS. Drug Discovery Today. 2004; 9(4):173–181.
[PubMed: 14960397]
115. Nesvizhskii AI, Aebersold R. Interpretation of shotgun proteomic data - The protein inference
problem. Mol. Cell. Proteomics. 2005; 4(10):1419–1440. [PubMed: 16009968]
116. Qian WJ, Jacobs JM, Liu T, Camp DG, Smith RD. Advances and challenges in liquid
chromatography-mass spectrometry-based proteomics profiling for clinical applications. Mol.
Cell. Proteomics. 2006; 5(10):1727–1744. [PubMed: 16887931]
117. Choi H, Ghosh D, Nesvizhskii AI. Statistical validation of peptide identifications in large-scale
proteomics using the target-decoy database search strategy and flexible mixture modeling. J.
Proteome Res. 2008; 7(1):286–292. [PubMed: 18078310]
118. Cargile BJ, Bundy JL, Stephenson JL. Potential for false positive identifications from large
databases through tandem mass spectrometry. J. Proteome Res. 2004; 3(5):1082–1085. [PubMed:
15473699]
119. Elias JE, Gygi SP. Target-decoy search strategy for increased confidence in large-scale protein
identifications by mass spectrometry. Nat. Methods. 2007; 4(3):207–214. [PubMed: 17327847]
120. Gupta N, Bandeira N, Keich U, Pevzner PA. Target-decoy approach and false discovery rate:
When things may go wrong. J. Am. Soc. Mass Spectrom. 2011; 22(7):1111–1120. [PubMed:
21953092]
Kalli et al. Page 22
J Proteome Res. Author manuscript; available in PMC 2014 July 05.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
Figure 1.
Suggested optimized MS and MS/MS parameters for the LTQ-Orbitrap. Values were
determined on the LTQ-Orbitrap Classic and XL and are taken from references [13], [15]
and [16].
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Figure 2.
Mass resolving power of the Orbitrap mass spectrometers is not steady across the m/z scan
range and decreases as the square root of the m/z ratio. Data from Orbitrap Classic at a set
mass resolving power of 60,000 (A) and Orbitrap Elite at a set mass resolving power of
120,000 (B).
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Figure 3.
Effect of MS/MS maximum ion injection time on identification rates observed for the
Orbitrap Elite.
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Figure 4.
Effect of MS resolving power on identification rates observed for the Orbitrap Elite.
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Figure 5.
Identification rates obtained in the LTQ-Orbitrap Classic and Orbitrap Elite under optimized
settings. (LTQ-Orbitrap Classic: 12 MS/MS events, 1 microscan, preview mode for FTMS
scan enabled, ion injection time for MS/MS 50 ms, AGC target value for MS/MS 5 × 103,
AGC target value for MS 5 × 105, mass resolving power 60, 000, Orbitrap Elite: 15 MS/MS
events, 1 microscan, preview mode for FTMS scan not enabled, ion injection time for MS/
MS 50 ms, AGC target value for MS/MS 5 × 103, AGC target value for MS 1 × 106, mass
resolving power 120, 000).
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Figure 6.
Identified proteins as a function of their cellular expression levels observed on the LTQ-
Orbitrap Classic and Orbitrap-Elite using the Saccharomyces cerevisiae proteome as the
model system. Protein cellular expression levels were obtained from reference [37]. The
number of identified proteins displayed in the Figure is a sum over two replicate analyses.
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Table 1
Summary of MS and MS/MS parameters discussed and values tested for each parameter with their associated
references.
MS parameter Values/Settings Examined Reference
Resolving power 7 500, 15 000, 30 000, 60 000, 100 000 [15]
Monoisotopic precursor selection Enabled/Disabled [13]
Preview mode for FTMS master scan Enabled/Disabled [16]
Minimum signal threshold for MS/MS 1 × 101, 1 × 102, 1 × 103, 1 × 104, 1 × 105, 1 × 106, 1 × 107 [14]
Number of microscans 1, 2, 3 [16]
Number of data dependent MS/MS 3, 5, 7, 8, 10, 12, 15, 20 [13, 16]
Automatic gain control (AGC) target value for MS 5 × 105, 8 × 105, 1 × 106, 2 × 106, 3 × 106 [16]
Automatic gain control (AGC) target value for MS/MS 1 × 103, 3 × 103, 5 × 103, 8 × 103, 1 × 104, 5 × 104, 1 × 105 [16]
Maximum ion injection time for MS/MS 50, 80, 100, 150, 200, 250, 400, 500 (ms) [13, 16]
Normalized collision energy 28% and 35% [13]
Dynamic exclusion duration 30 sec and 180 sec [13]
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Table 2
Set and actual ion injection time for different (A) MS and (B) MS/MS AGC target values.
A.
AGC target
value for
MS
Set MS
ion injection
time (ms)
Actual MS
ion injection
time (ms)a
5 × 105 700 18 (±3)
8 × 105 700 35 (±6)
1 × 106 700 64 (±10)
2 × 106 700 97 (±10)
3 × 106 700 150 (±10)
B.
AGC target
value for
MS/MS
Set MS/MS
ion injection
time (ms)
Actual MS/MS
ion injection
time (ms)a
1 × 103 500 11 (±1)
3 × 103 500 33 (±2)
5 × 103 500 51 (±6)
8 × 103 500 85 (±9)
1 × 104 500 115 (±9)
5 × 104 500 361 (±10)
1 × 105 500 440 (±9)
aActual ion injection times were obtained from LogViewer.18
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Table 3
MS and MS/MS parameters examined for the Orbitrap Elite. Recommended settings are also indicated.
MS parameter Values/SettingsExamined
Recommended
Settings
Automatic gain control (AQC) target value for MS 5 × 105, 8 × 105, 1 × 106 5 × 106−1 × 106
Automatic gain control (AGO) target value for MS/MS 3 × 103, 5 × 103, 8 × 103, 1 × 104 3 × 103−1 × 104
Maximum Ion Injection time for MS/MS 30, 50, 100, 150, 200 (ms) 30 – 100 (ma)
Number of data dependent MS/MS 15 and 20 15–20
Resolving power 30 000, 60 000, 120 000, 240 000 120 000
Scan rate for MS/MS events Rapid and Normal Rapid
Predict Ion Injection time Enabled/Disabled Enabled
Preview mode for FTMS master aaan Enabled/Disabled Disabled
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Table 7
MS and MS/MS settings employed during HCD analysis on different Orbitrap mass analyzers
MS and MS/MS settings LTQ-Orbitrap Velos Q Exactive Q Exactive Orbitrap Elite
Model system HeLa lysate Yeast lysate HeLa lysate Yeast lysate HeLa lysate
Amount loaded 5 µg 5 – 250 ng (yeast) 1 µg (HeLa) 4 µg 400 ng
LC gradient duration 120 min 60 min, 120 min, 180 min 240 min 120 min
Resolving power MSa 30,000 70,000 70,000 120,000
Resolving power MS/MSa 7,500 17,500b 35,000c 17,500 15,000
Minimum signal threshold for MS/MS 5 × 103 1 × 105 Not specified 5 × 103#
Number of data dependent MS/MS 10 12 10 15
AGC target value for MS 1 × 106 1 × 106 1 × 106 1 × 106
AGC target value for MS/MS 3 × 104 or 5 × 104 5 × 105 1 × 106 4 × 104
Maximum ion injection time for MS 500 ms 120 ms 20 ms 100 ms#
Maximum ion injection time for MS/MS 250 ms 60 msb 120 msc 60 ms 150 ms#
Normalized collision energy 40% 25 % 25 % 35%#
Dynamic exclusion duration 120 sec* 30 sec 40 sec 60 sec
Isolation width 5 Da* 1.2 Da (yeast) 2.0 Da (HeLa) 1.6 Da 2.0 Da
Reference [30] [39] [40] [36]
a
Mass resolving power on the Orbitrap is specified at m/z = 400 and on the Q Exactive at m/z = 200
b
Mass resolving power of 17, 5000 was combined with a maximum injection time of 60 ms
c
Mass resolving power of 35, 5000 was combined with a maximum injection time of 120 ms
#Stevan Horning, personal communication
*
Matthias Mann, personal communication
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